TEVA-PHARMA - PRODUTOS FARMACEUTICOS, LDA. secures contract for Call For Proposals Under The Framework Agreement S 2023 436 - Medicines For The Central Nervous System 2023 491 - Oncological Medicines And Immunomodulators 2023 492 - M

Portugal, March 13 -- Portugal based TEVA-PHARMA - PRODUTOS FARMACEUTICOS, LDA. has secured contract from Unidade Local De Saude Da Regiao De Leiria, E. P. E. for Call For Proposals Under The Framework Agreement S 2023 436 - Medicines For The Central Nervous System 2023 491 - Oncological Medicines And Immunomodulators 2023 492 - M. The value of the contract is worth 3216400 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....